ERBB2 and central nervous system cancer: It is thus appropriate for our study, since 76% of glioblastomas are positive for EGFR-neu, whereas normal tissue expresses little if any EGFR-neu [26], together with the fact that Lindberg and colleagues used Oli-neu cells to demonstrate that OPCs can act as cells of origin for experimental glioma [24].